Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand

Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand

To overcome pandemics, such as COVID-19, vaccines are urgently needed at very high volumes. Here we assess the techno-economic feasibility of producing RNA vaccines for the demand associated with a global vaccination campaign. Production process performance is assessed for three messenger RNA (mRNA)...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Zoltán Kis, Cleo Kontoravdi, Robin Shattock, Nilay Shah
Formáid:	Alt
Teanga:	English
Foilsithe / Cruthaithe:	MDPI AG 2020-12-01
Sraith:	Vaccines
Ábhair:	RNA vaccines mRNA vaccines saRNA vaccines pandemic-response vaccine production COVID-19 production process modelling
Rochtain ar líne:	https://www.mdpi.com/2076-393X/9/1/3

Míreanna comhchosúla

A self-amplifying RNA vaccine provides protection in a murine model of bubonic plague
de réir: Robin John Shattock, et al.
Foilsithe / Cruthaithe: (2023-11-01)

Vaccines’ New Era-RNA Vaccine
de réir: Wenshuo Zhou, et al.
Foilsithe / Cruthaithe: (2023-08-01)

Advancing mRNA technologies for therapies and vaccines: An African context
de réir: Dylan Kairuz, et al.
Foilsithe / Cruthaithe: (2022-10-01)

The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview
de réir: Bruna Aparecida Souza Machado, et al.
Foilsithe / Cruthaithe: (2021-11-01)

Evaluation of a self-amplifying mRNA reporter vaccine in explant models of broiler chickens
de réir: Janne Snoeck, et al.
Foilsithe / Cruthaithe: (2023-11-01)

The Current Landscape of mRNA Vaccines Against Viruses and Cancer–A Mini Review
de réir: Reese Jalal Ladak, et al.
Foilsithe / Cruthaithe: (2022-05-01)

Advances in saRNA Vaccine Research against Emerging/Re-Emerging Viruses
de réir: Yalan Liu, et al.
Foilsithe / Cruthaithe: (2023-06-01)

In Vitro Transcribed RNA-Based Platform Vaccines: Past, Present, and Future
de réir: Alexey D. Perenkov, et al.
Foilsithe / Cruthaithe: (2023-10-01)

Editorial: RNA vaccines for prevalent and newly emerging diseases
de réir: César López-Camacho, et al.
Foilsithe / Cruthaithe: (2024-08-01)

Development of mRNA rabies vaccines
de réir: Zixin Fang, et al.
Foilsithe / Cruthaithe: (2024-12-01)

A Lipid Nanoparticle-Formulated Self-Amplifying RNA Rift Valley Fever Vaccine Induces a Robust Humoral Immune Response in Mice
de réir: Paul K. Kitandwe, et al.
Foilsithe / Cruthaithe: (2024-09-01)

Production, Characterization, and Assessment of Permanently Cationic and Ionizable Lipid Nanoparticles for Use in the Delivery of Self-Amplifying RNA Vaccines
de réir: Dylan Kairuz, et al.
Foilsithe / Cruthaithe: (2023-04-01)

Efficient mRNA Delivery with mRNA Lipoplexes Prepared Using a Modified Ethanol Injection Method
de réir: Min Tang, et al.
Foilsithe / Cruthaithe: (2023-04-01)

Advantages of Broad-Spectrum Influenza mRNA Vaccines and Their Impact on Pulmonary Influenza
de réir: Ziqi Cheng, et al.
Foilsithe / Cruthaithe: (2024-12-01)

Post-RNA (mRNA) Vaccination Myocarditis: CMR Features
de réir: Karuna M. Das, et al.
Foilsithe / Cruthaithe: (2022-04-01)

RNA-based vaccines – types, strategies of delivery and overview of RNA vaccines
de réir: Barbara Rusinowska, et al.
Foilsithe / Cruthaithe: (2022-08-01)

Immunogenicity of HIV-1 <i>Env</i> mRNA and <i>Env-Gag</i> VLP mRNA Vaccines in Mice
de réir: Qi Ma, et al.
Foilsithe / Cruthaithe: (2025-01-01)

An mRNA vaccine against rabies provides strong and durable protection in mice
de réir: Miao Li, et al.
Foilsithe / Cruthaithe: (2023-10-01)

Opportunities and challenges to implementing mRNA-based vaccines and medicines: lessons from COVID-19
de réir: Shehzad M. Iqbal, et al.
Foilsithe / Cruthaithe: (2024-08-01)

Safety and immunogenicity of an mRNA-1273 vaccine booster in adolescents
de réir: Amparo L. Figueroa, et al.
Foilsithe / Cruthaithe: (2025-12-01)

mRNA cancer vaccines from bench to bedside: a new era in cancer immunotherapy
de réir: Alireza Shariati, et al.
Foilsithe / Cruthaithe: (2024-12-01)

From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape
de réir: Chiranjib Chakraborty, et al.
Foilsithe / Cruthaithe: (2021-07-01)

RETRACTED ARTICLE: An overview on mRNA-based vaccines to prevent monkeypox infection
de réir: Mohammad Natami, et al.
Foilsithe / Cruthaithe: (2024-03-01)

Serological findings following the second and third SARS‐CoV‐2 vaccines in lung transplant recipients
de réir: Enikő Bárczi, et al.
Foilsithe / Cruthaithe: (2022-08-01)

The Pivotal Role of Chemical Modifications in mRNA Therapeutics
de réir: Albert Liu, et al.
Foilsithe / Cruthaithe: (2022-07-01)

Concomitant administration of seasonal influenza and COVID-19 mRNA vaccines
de réir: Teresa Aydillo, et al.
Foilsithe / Cruthaithe: (2024-12-01)

COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events
de réir: Girolamo Giannotta, et al.
Foilsithe / Cruthaithe: (2023-03-01)

Effectiveness of mRNA COVID-19 Vaccination on SARS-CoV-2 Infection and COVID-19 in Sicily over an Eight-Month Period
de réir: Emanuele Amodio, et al.
Foilsithe / Cruthaithe: (2022-03-01)

Anion exchange HPLC monitoring of mRNA in vitro transcription reactions to support mRNA manufacturing process development
de réir: Emma N. Welbourne, et al.
Foilsithe / Cruthaithe: (2024-03-01)

Universal Flu mRNA Vaccine: Promises, Prospects, and Problems
de réir: Andrei A. Deviatkin, et al.
Foilsithe / Cruthaithe: (2022-04-01)

An Overview on the Development of mRNA-Based Vaccines and Their Formulation Strategies for Improved Antigen Expression In Vivo
de réir: Md. Motiar Rahman, et al.
Foilsithe / Cruthaithe: (2021-03-01)

Editorial: Building public confidence in innovative mRNA vaccines
de réir: Jia Hu, et al.
Foilsithe / Cruthaithe: (2025-01-01)

mRNA-Based Vaccine for COVID-19: They Are New but Not Unknown!
de réir: Vivek P. Chavda, et al.
Foilsithe / Cruthaithe: (2023-02-01)

Advances in nucleic acid-based cancer vaccines
de réir: Hung-Chun Liao, et al.
Foilsithe / Cruthaithe: (2025-01-01)

Safety and Efficacy of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Different Vaccines at Phase 3
de réir: Yu-Jing Fan, et al.
Foilsithe / Cruthaithe: (2021-09-01)

A Multicenter Cohort Study on the Adverse Effects Evaluation After Messenger RNA COVID-19 Vaccination Among Pregnant Healthcare Employees in Penang General Hospitals
de réir: Ann Lisa Arulappen, et al.
Foilsithe / Cruthaithe: (2022-05-01)

Stability Modelling of mRNA Vaccine Quality Based on Temperature Monitoring throughout the Distribution Chain
de réir: Zoltán Kis
Foilsithe / Cruthaithe: (2022-02-01)

Strategy of developing nucleic acid-based universal monkeypox vaccine candidates
de réir: Dimitri Papukashvili, et al.
Foilsithe / Cruthaithe: (2022-10-01)

Dendrimer-Mediated Delivery of DNA and RNA Vaccines
de réir: Lyubov A. Kisakova, et al.
Foilsithe / Cruthaithe: (2023-03-01)

mRNA Technology and Mucosal Immunization
de réir: Antonio Toniolo, et al.
Foilsithe / Cruthaithe: (2024-06-01)